Vaccine Information Statements |
|
Measles, Mumps, Rubella (MMR) VIS |
|
|
|
|
| |
|
|
| NOTE: The MMR VIS (4/20/12) is the first VIS to feature a 2D barcode. Healthcare providers, who have the appropriate barcode reader and software, will have the option of scanning the VIS name and edition date into an electronic system. For more information, see CDC's VIS barcode web page. |
| |
Up-to-date translations |
|
|
|
| You are encouraged to distribute the up-to-date
English-language version at the same time as the translation. |
|
|
|
|
|
|
| |
Out-of-date translations |
|
|
|
| The translations for some VISs on our website are from previously
published English-language versions that have since been updated.
Unfortunately, IAC is not always able to obtain translations as
updates are issued. Please ensure that your patients receive
information consistent with the current
English-language version of the following VISs. |
|
|
| TRANSLATIONS OF THE MARCH 13, 2008 MMR VIS |
|
|
|
|
|
|
| These translations do not
contain the following CDC updates: |
|
| • |
|
Section 2, sentence has been
added noting that children younger than 12 months who are
traveling out of the country should get a dose of MMR; |
|
|
|
| • |
|
Section 3, a note has been added asking the patient to tell their provider if they received another vaccine within the
past 4 weeks (to alert the provider of the possibility of administering two live vaccines too close together); |
|
|
|
| • |
|
Section 4, the statement that minor problems usually occur 7-12 days after the shot was changed to the more accurate 6-14
days; and |
|
|
|
| • |
|
Box noting the risk of adverse events following MMRV
was removed, as it is not relevant for patients receiving
MMR. |
|
|
|
| • |
|
This VIS is the
first to feature a 2D barcode, which will allow providers to
scan selected information into the patient's record or into
an immunization information system. |
|
|
|
| TRANSLATIONS OF THE JANUARY 15, 2003 MMR VIS |
|
|
|
|
|
|
| These translations do not
contain the following CDC updates: |
|
| • |
|
Information was added about MMRV vaccine, tied to the March 14 MMWR, regarding increased risk of certain adverse events, including febrile seizures, with MMRV when compared with MMR and varicella vaccines given separately. Aside from two boxes containing information about MMRV, both VISs are identical to the previous editions. |
|
|
|
| • |
|
The new VISs should be used when MMRV is given; but the existing stocks of the individual MMR and varicella VISs may be used when the vaccines are given separately. |
|
|
|
| TRANSLATIONS OF THE DECEMBER 16, 1998 MMR VIS |
|
|
|
|
|
|
| This translation does not contain
the following CDC updates: |
|
| • |
|
Information
was added about MMRV vaccine, tied to the March 14 MMWR,
regarding increased risk of certain adverse events,
including febrile seizures, with MMRV when compared with MMR
and varicella vaccines given separately. Aside from two
boxes containing information about MMRV, both VISs are
identical to the previous editions. |
|
|
|
| • |
|
The new VISs
should be used when MMRV is given; but the existing stocks
of the individual MMR and varicella VISs may be used when
the vaccines are given separately. |
|
A-Z
